Elevated white blood cell count in subjects with impaired glucose tolerance
Related Experiment Video
Updated: Aug 29, 2026

Study of In Vivo Glucose Metabolism in High-fat Diet-fed Mice Using Oral Glucose Tolerance Test (OGTT) and Insulin Tolerance Test (ITT)
Published on: January 7, 2018
Kayo Ohshita1, Kiminori Yamane, Miki Hanafusa
1Department of Molecular and Internal Medicine, Division of Clinical Medical Science, Programs for Applied Biomedicine, Graduate School of Biomedical Sciences, Hiroshima University, Hiroshima, Japan. kayoo@hiroshima-u.ac.jp
Insights
Individuals with isolated impaired glucose tolerance (IGT) had higher white blood cell (WBC) counts than those with isolated impaired fasting glucose (IFG). WBC count is linked to 2-hour plasma glucose and metabolic syndrome components.
Area of Science:
- Endocrinology
- Metabolic Syndrome Research
- Clinical Biochemistry
Background:
- Impaired glucose tolerance (IGT) and impaired fasting glucose (IFG) are distinct prediabetic states with varying mortality risks.
- Previous studies indicated minimal differences in lipids or blood pressure between IFG and IGT.
- White blood cell (WBC) count as a potential differentiator between IFG and IGT warrants investigation.
Purpose of the Study:
- To compare white blood cell (WBC) counts between individuals with isolated impaired fasting glucose (IFG) and isolated impaired glucose tolerance (IGT).
- To identify factors associated with WBC count in nondiabetic Japanese men.
Main Methods:
- A cross-sectional study involving 4,720 nondiabetic Japanese men aged 24-84 years.
- Classification into four groups based on a 75-g oral glucose tolerance test: normal glucose tolerance/normal fasting glucose, isolated IFG, isolated IGT, and IFG/IGT.
- Comparison of WBC counts among groups and stepwise analysis to identify associated variables.
Main Results:
- The isolated IGT group exhibited a significantly higher WBC count compared to the isolated IFG group (6,530 vs. 6,210/mm(3), P < 0.05).
- Age, triglycerides, HDL cholesterol, fasting insulin, and 2-hour postchallenge plasma glucose (PG) were independently associated with WBC count (adjusted R(2) = 0.057).
- WBC count was independently associated with 2-hour PG and triglycerides, regardless of smoking status.
Conclusions:
- Isolated impaired glucose tolerance is associated with a higher white blood cell count than isolated impaired fasting glucose.
- White blood cell count demonstrates an association with 2-hour plasma glucose and key metabolic syndrome components.
- These findings suggest WBC count may serve as a biomarker differentiating prediabetic states.
Objective:
Impaired glucose tolerance (IGT) and impaired fasting glucose (IFG) differ in their risk of all-cause and cardiovascular mortality, but previous cross-sectional studies have suggested little difference in their levels of lipids or blood pressure. We compared the white blood cell (WBC) count between subjects with IFG and IGT.
Research Design And Methods:
The subjects were 4,720 nondiabetic Japanese men aged 24-84 years. Based on the 75-g oral glucose tolerance test, the subjects were classified into the following four groups: normal fasting glucose/normal glucose tolerance (n = 3,753), isolated IFG (n = 290), isolated IGT (n = 476), and IFG/IGT (n = 201). We compared the WBC count among the four groups and investigated variables that showed a significant association with the WBC count.
Results:
The isolated IGT group had a significantly higher WBC count than the isolated IFG group (6,530 vs. 6,210/mm(3), P < 0.05). By stepwise analyses, age, triglycerides, HDL cholesterol, fasting insulin, and 2-h postchallenge plasma glucose (PG) showed an independent association with the WBC count (adjusted R(2) = 0.057). In the analysis stratified by smoking status, the WBC count was independently associated with 2-h PG and triglycerides, irrespective of smoking status.
Conclusions:
Individuals with isolated IGT had a significantly higher WBC count than those with isolated IFG. The WBC count was associated with 2-h PG and various components of the metabolic syndrome.
Related Concept Videos
Hyperglycemia
Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis
Diabetes: Symptoms, Diagnosis, and Complications
Diabetes Mellitus: Type 2 and Gestational
Type I Diabetes III: Clinical Manifestations
Type II Diabetes II: Pathophysiology
